224 related articles for article (PubMed ID: 22365514)
1. Prognostic factors and staging for soft tissue sarcomas: an update.
Jones NB; Iwenofu H; Scharschmidt T; Kraybill W
Surg Oncol Clin N Am; 2012 Apr; 21(2):187-200. PubMed ID: 22365514
[TBL] [Abstract][Full Text] [Related]
2. Principles of staging of soft-tissue sarcomas.
Peabody TD; Simon MA
Clin Orthop Relat Res; 1993 Apr; (289):19-31. PubMed ID: 8472413
[TBL] [Abstract][Full Text] [Related]
3. [Pathological evaluation of soft tissue sarcoma for diagnosis, prognosis and treatment].
Yamaguchi U; Hasegawa T
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1340-5. PubMed ID: 15446553
[TBL] [Abstract][Full Text] [Related]
4. Grading in soft tissue tumors: principles and problems.
Oliveira AM; Nascimento AG
Skeletal Radiol; 2001 Oct; 30(10):543-59. PubMed ID: 11685477
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk.
Hasegawa T; Yamamoto S; Yokoyama R; Umeda T; Matsuno Y; Hirohashi S
Cancer; 2002 Aug; 95(4):843-51. PubMed ID: 12209729
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in soft tissue sarcoma. A review and the Scandinavian Sarcoma Group experience.
Rydholm A; Gustafson P; Alvegård TA; Saeter G; Blomqvist C
Acta Orthop Scand Suppl; 1999 Jun; 285():50-7. PubMed ID: 10429623
[No Abstract] [Full Text] [Related]
7. Utility of positron emission tomography in sarcomas.
Schuetze SM
Curr Opin Oncol; 2006 Jul; 18(4):369-73. PubMed ID: 16721133
[TBL] [Abstract][Full Text] [Related]
8. [Interdisciplinary detection of soft tissue sarcomas. Diagnosis, grading and staging].
Leyvraz S; Costa J
Orthopade; 1988 Apr; 17(2):121-7. PubMed ID: 3290794
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic considerations: how can we fine tune our approach to sarcoma?
Demicco EG; Lazar AJ
Semin Oncol; 2011 Oct; 38 Suppl 3():S3-18. PubMed ID: 22055969
[TBL] [Abstract][Full Text] [Related]
10. [Soft tissue sarcoma in adulthood].
Schmidt-Matthiesen A; Hovy L; Encke A
Zentralbl Chir; 1992; 117(7):374-88. PubMed ID: 1414047
[TBL] [Abstract][Full Text] [Related]
11. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
Genevay M; Gengler C; Guillou L
Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of prognostic indicators for sarcomas of the soft parts and the viscerae.
Rudolph P; Bonichon F; Gloeckner K; Collin F; Chassevent A; Schmidt D; Coindre JM; Parwaresch R; Klöppel G
Verh Dtsch Ges Pathol; 1998; 82():246-52. PubMed ID: 10095442
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
[TBL] [Abstract][Full Text] [Related]
14. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
[TBL] [Abstract][Full Text] [Related]
15. Treatment of adult soft tissue sarcoma: old concepts, new insights, and potential for drug discovery.
Aragon-Ching JB; Maki RG
Cancer Invest; 2012 May; 30(4):300-8. PubMed ID: 22480231
[TBL] [Abstract][Full Text] [Related]
16. Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database.
Salas S; Stoeckle E; Collin F; Bui B; Terrier P; Guillou L; Trassard M; Ranchere-Vince D; Gregoire F; Coindre JM
Eur J Cancer; 2009 Aug; 45(12):2091-102. PubMed ID: 19351580
[TBL] [Abstract][Full Text] [Related]
17. Histological grading and MIB-1 labeling index of soft-tissue sarcomas.
Hasegawa T
Pathol Int; 2007 Mar; 57(3):121-5. PubMed ID: 17295643
[TBL] [Abstract][Full Text] [Related]
18. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
[TBL] [Abstract][Full Text] [Related]
19. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
20. Nonrhabdomyosarcomatous soft tissue sarcomas of childhood: formulation of a simplified system for grading.
Parham DM; Webber BL; Jenkins JJ; Cantor AB; Maurer HM
Mod Pathol; 1995 Sep; 8(7):705-10. PubMed ID: 8539226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
